Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 458 of 1,261
  1. WO 2019224246

    MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE

    ALK ABELLO AS [DK] · Granted Nov 28, 2019 · Expires Nov 23, 2039

    granted
  2. US 10488416

    Targeting breast cancer therapy based on stromal subtypes and CD146 composition

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  3. US 10487088

    Tricyclic compound serving as immunomodulator

    Medshine Discovery Inc. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  4. US 10487076

    Compositions and methods for treating diseases and conditions

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  5. US 10485774

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  6. US 10485792

    Sustained release delivery systems for the prevention and treatment of head and neck cancers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  7. US 10485829

    Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells

    Astellas Institute for Regenerative Medicine · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  8. US 10485850

    Methods for producing stable therapeutic formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  9. US 10485879

    Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues

    Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  10. US 10485886

    Core-satellite nanocomposites for MRI and photothermal therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  11. US 10488417

    Compounds for use as imaging agents

    UNITED ARAB EMIRATES UNIVERSITY · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  12. US 10487341

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  13. US 10487326

    Peptide oligonucleotide conjugates

    Sarepta Therapeutics, Inc. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  14. US 10487148

    Methods and compositions for treating aging-associated impairments

    The Regents of the University of California · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  15. US 10487113

    Peptide having activity to improve skin condition and use thereof

    CAREGEN CO., LTD. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  16. US 10487105

    Trinucleotide MRNA cap analogs

    ARCTURUS THERAPEUTICS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  17. US 10487145

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  18. US 10487140

    Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  19. US 10487054

    Therapeutic compounds

    Regents of the University of Minnesota · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  20. US 10485959

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  21. US 10485958

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  22. US 10485877

    Oligomer-phenothiazine conjugates

    Nektar Therapeutics · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  23. US 10485844

    Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  24. US 10485871

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.